Friday, August 01, 2025 4:12:12 PM
Ever played the game… I See Something? I spy with my little eye?
As the week ends now at resistance step 11.25, after an opening tumble to the key 10.60 target… the smallish bounce to 11.25 is creating an interesting picture now, possibly setting up the next move for early next week.
It’s a key zone right here, that might represent a chance for the pattern to regain its bullish momentum, I want to see a strong surge up 1 dollar from this launch pad around 11.20/11.10 holding and surging to the 12.20 target resistance. Anything short of 12, like seeing it stall and fail around 11.70/11.55, could become a bearish bias, in my calculation, losing the bullish momentum, acting like it wants to stall and roll over, and tumble right back down , to continue its down wave.
It’s worth watching next week’s price action for this very next move, on deck. The battle between support holding 11 dollars versus resistance rolling over around 11.60
The up wave bullish pattern wants to hold around 11.30 area … it has a chance to regain that now. But the down wave wants to cap and roll over around 11.50/11.65, like it did last time. Watch this battle next week.
And remember that opening surge to 12.67 this week that completely erased??? The real resistance remained around 11.60, where it rolled over, as anticipated and tumbled 1 dollar to the 10.60 pivot low.
it’s all fun with numbers and math.
As the week ends now at resistance step 11.25, after an opening tumble to the key 10.60 target… the smallish bounce to 11.25 is creating an interesting picture now, possibly setting up the next move for early next week.
It’s a key zone right here, that might represent a chance for the pattern to regain its bullish momentum, I want to see a strong surge up 1 dollar from this launch pad around 11.20/11.10 holding and surging to the 12.20 target resistance. Anything short of 12, like seeing it stall and fail around 11.70/11.55, could become a bearish bias, in my calculation, losing the bullish momentum, acting like it wants to stall and roll over, and tumble right back down , to continue its down wave.
It’s worth watching next week’s price action for this very next move, on deck. The battle between support holding 11 dollars versus resistance rolling over around 11.60
The up wave bullish pattern wants to hold around 11.30 area … it has a chance to regain that now. But the down wave wants to cap and roll over around 11.50/11.65, like it did last time. Watch this battle next week.
And remember that opening surge to 12.67 this week that completely erased??? The real resistance remained around 11.60, where it rolled over, as anticipated and tumbled 1 dollar to the 10.60 pivot low.
it’s all fun with numbers and math.
Bullish
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
